Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel disease.
Stefanos BonovasG FiorinoT LytrasG NikolopoulosL Peyrin-BirouletS DanesePublished in: Alimentary pharmacology & therapeutics (2017)
Our findings support a potential chemopreventive role of 5-aminosalicylates in IBD. Further, high-quality prospective research is warranted.